Inflation Reduction Act Drug Negotiation Sign On Letter to CMS

The GFPD is one of 101 organizations that recently sent a letter to CMS regarding implications from the Inflation Reducation Act of 2022.  As the Centers for Medicare and Medicaid Services (CMS) continues to implement the provisions of this law, the GFPD urges CMS to further consider the unique perspective and challenges faced by rare disease patients and provides the following recommendations to ensure this law best serves the needs of the rare disease community.